Clazakizumab
5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Clazakizumab for atherosclerosis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Clazakizumab for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Clazakizumab for hypertension | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Clazakizumab for obesity | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Clazakizumab for renal insufficiency, chronic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |